News Flaggemelding Staff August 22, 2025 Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holding ASA. Iframe sync Post navigation Previous: Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment ConferenceNext: Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP) More Stories News Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures Staff January 17, 2026 Diagnostics News DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye Staff January 16, 2026 News Pharmaceutical NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress Staff January 16, 2026
